NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia

Law Amanda J.

首页> 外文期刊>Schizophrenia research >NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia

【24h】

NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia

机译：NRG1 / ErbB4和PI3K / AKT途径：精神分裂症的新治疗选择

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Schizophrenia research》 |2014年第3期|共5页
作者
Law Amanda J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia [J] . Law Amanda J. Schizophrenia research . 2014,第1a3期

机译：NRG1 / ErbB4和PI3K / AKT途径：精神分裂症的新治疗选择
2. Qiliqiangxin protects cardiac myocytes against hypoxia-induced apoptosis via ErbB4/PI3K/Akt pathway [J] . Chuhang Qing, Jingjing Zhang, Jingmin Zhou, International Journal of Clinical and Experimental Medicine . 2016,第6期

机译：七里强新通过ErbB4 / PI3K / Akt通路保护心肌细胞免受缺氧诱导的细胞凋亡
3. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway [J] . Dongshao Chen, Xiaoting Lin, Cheng Zhang, Cell death & disease. . 2018,第2期

机译：双PI3K / MTOR抑制剂BEZ235作为对紫杉醇抗性胃癌的有前途的治疗策略，通过靶向PI3K / AKT / MTOR途径
4. Inspecting the Role of PI3K/AKT Signaling Pathway in Cancer Development Using an In Silico Modeling and Simulation Approach [C] . Pedro Pablo Gonzalez-Perez, Maura Cardenas-Garcia International work-conference on bioinformatics and biomedical engineering . 2018

机译：使用计算机模拟和仿真方法检查PI3K / AKT信号通路在癌症发展中的作用
5. PIK3IP1/TrIP Restricts Activation of T Cells Through Inhibition of the PI3K/Akt Pathway [D] . Uche, Uzodinma Nnaemeka. 2018

机译：Pik3ip1 /旅行通过抑制PI3K / AKT路径来限制T细胞的激活
6. NRG1 ERBB4 and AKT1 Epistasis Increases Schizophrenia Risk and is Biologically Validated via Functional Neuroimaging in Healthy Controls [O] . Kristin K. Nicodemus, Amanda J. Law, Eugenia Radulescu, -1

机译：NRG1ERBB4和aKT1上位通过脑功能成像增加精神分裂症风险生物验证健康对照组
7. Biological Validation of Increased Schizophrenia Risk With NRG1, ERBB4, and AKT1 Epistasis via Functional Neuroimaging in Healthy Controls [O] . Kristin K. Nicodemus, Amanda J. Law, Eugenia Radulescu, 2010

机译：通过在健康对照中的功能性神经模仿，NRG1，ERBB4和AKT1简化的生物学验证增加的精神分裂症风险

NRG1/ErbB4 and the PI3K/AKT pathway: Novel therapeutic options for schizophrenia

著录项

相似文献

相关主题

期刊订阅